Issued Patents All Time
Showing 25 most recent of 43 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10494416 | Methods of modulating immune responses using BCMA polypeptide | Christine Ambrose, Fabienne MacKay, Jurg Tschopp, Pascal Schneider, Jeffrey Thompson | 2019-12-03 |
| 9650430 | Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA) | Christine Ambrose, Fabienne MacKay, Jurg Tschopp, Pascal Schneider, Jeffrey Thompson | 2017-05-16 |
| 8828669 | Methods of screening for a compound that inhibits the interaction between BAFF and BCMA | Christine Ambrose, Fabienne MacKay, Jurg Tschopp, Pascal Schneider, Jeffrey Thompson | 2014-09-09 |
| 8709759 | Method for increasing expression of active tumor necrosis factor receptor family member-Ig fusion proteins | Konrad Miatkowski, Werner Meier | 2014-04-29 |
| 8455445 | Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders | Christopher D. Benjamin, Paula S. Hochman | 2013-06-04 |
| 8338376 | Compositions comprising variant LT-B-R-IG fusion proteins | Evan Beckman, Graham K. Farrington, Werner Meier | 2012-12-25 |
| 8287874 | Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases | Paula S. Hochman, Paul Rennert, Fabienne MacKay | 2012-10-16 |
| 8283138 | Method for the high level expression of active tumor necrosis receptor family member immunoglobulin fusion proteins | Konrad Miatkowski, Werner Meier | 2012-10-09 |
| 8142779 | Treatment of follicular lymphomas using inhibitors of the LT pathway | Jeanette Thorbecke, Vincent Tsiagbe | 2012-03-27 |
| 8067375 | Treatment of demyelinating disorders with soluble lymphotoxin-β-receptor | Jenny P.-Y. Ting | 2011-11-29 |
| 7951371 | Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling | Christopher D. Benjamin, Paula S. Hochman | 2011-05-31 |
| 7947271 | Methods of decreasing tumor volume and reducing tumor burden using TNF-receptor-coupling agents | Veronique Bailly, Ellen Garber | 2011-05-24 |
| 7846438 | Methods of promoting neurite outgrowth with soluble TAJ polypeptides | Sha Mi | 2010-12-07 |
| 7799902 | Receptor coupling agents and compositions thereof | Veronique Bailly, Ellen Garber | 2010-09-21 |
| 7744891 | Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases | Paula S. Hochman, Paul Rennert, Fabienne MacKay | 2010-06-29 |
| 7731963 | TWEAK receptor agonists as anti-angiogenic agents | Linda C. Burkly, Aniela Jakubowski, Timothy Zheng | 2010-06-08 |
| 7695934 | Tumor necrosis factor related ligand | Yves Chicheportiche | 2010-04-13 |
| 7618933 | Treatment of follicular lymphomas using inhibitors of the LT pathway | Jeanette Thorbecke, Vincent Tsiagbe | 2009-11-17 |
| 7585946 | Active lymphotoxin-β receptor immunoglobulin chimeric protein compositions | Konrad Miatkowski, Werner Meier | 2009-09-08 |
| 7566769 | Tumor necrosis factor related ligand | Yves Chicheportiche | 2009-07-28 |
| 7459537 | Anti-lymphotoxin-β receptor antibodies as anti-tumor agents | Werner Meier, Christopher D. Benjamin | 2008-12-02 |
| 7452530 | Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway | Maryann Puglielli, Rafi Ahmed | 2008-11-18 |
| 7427403 | Methods for inhibiting lymphotoxin β receptor signalling | Christopher D. Benjamin, Paula S. Hochman | 2008-09-23 |
| 7309492 | Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of systemic lupus erythematosus | Paula S. Hochman, Paul Rennert, Fabienne MacKay | 2007-12-18 |
| 7255854 | Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases | Paula S. Hochman, Paul Rennert, Fabienne MacKay | 2007-08-14 |